193 results on '"J. Lowe"'
Search Results
2. Exploration of visual hallucinations – FDG‐PET associations in DLB and MCI‐LB with and without visual hallucinations
3. TAR DNA‐binding protein 43 (TDP‐43) contributes to the mismatch between medial temporal volumes and flortaucipir uptake in elderly patients with Alzheimer’s disease neuropathologic changes
4. Latent space projection of brain FDG‐PET creates a powerful classifier for neurodegenerative diseases
5. Unique brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy
6. Baseline and Longitudinal Ioflupane SPECT Findings in DLB and MCI‐LB
7. Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia
8. Deciphering the clinico‐radiological heterogeneity of dysexecutive Alzheimer’s disease using unsupervised machine learning techniques
9. A longitudinal investigation of physical and cognitive activities and the outcome of trajectories of AD neuroimaging biomarkers: The Mayo Clinic Study of Aging
10. Amyloid PET in the Lewy Body disease continuum
11. Amyloid independent pathways have an impact on longitudinal tau deposition
12. White Matter Degeneration Pathways Associated with Tau Deposition in Alzheimer’s Disease
13. White matter health in the context of Alzheimer’s disease pathophysiology
14. Potential for Re‐Identifying Brain PET Research Participants using Face Recognition
15. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
16. Baseline CSF phosphorylated tau as an indicator of subsequent tau accumulation on tau PET
17. Potential utility of longitudinal 123 I‐FP‐CIT SPECT imaging in predicting phenoconversion to overt synucleinopathy in isolated REM sleep behavior disorder
18. An examination of atypical primary progressive aphasia variants
19. Optimizing software methods for measuring flortaucipir SUVR change over time
20. The Overlap Index: A new means for early detection of serial tau PET signal change
21. Neurochemical levels measured by 1 H MR spectroscopy are associated with amyloid‐β and tau deposition in cognitively unimpaired older adults
22. Comparison of Pittsburgh compound‐B and flutemetamol white matter binding
23. Higher systolic and diastolic blood pressures are associated with loss of white matter integrity in postmenopausal women of the KEEPS Continuation Study
24. Tau‐positron emission tomography correlates with neuropathology findings
25. Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele
26. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease
27. Asymmetric caudate hypometabolism in the absence of frontal involvement on FDG‐PET in patients with semantic dementia and behavioral symptoms
28. Progressive dysexecutive syndrome due to Alzheimer’s disease: A description of 55 cases and comparisons to other clinical AD phenotypes
29. CD33 , MEF2C , and SORL1 are associated with variability in macroscale functional brain architecture in AD
30. Functional connectivity is associated with tau spreading in dementia with Lewy bodies
31. Multiple sclerosis is associated with lower amyloid but normal tau burden on PET
32. Evaluation of a retinal deep phenotyping platform to detect the likely cerebral amyloid PET status in humans
33. Disrupted brain dynamics across the Alzheimer’s disease spectrum is related to tau accumulation
34. Heterogeneity in longitudinal deterioration of white matter microstructural integrity in the population and its implications for cognitive aging
35. Blood‐brain barrier insulin resistance decreases insulin uptake and increases amyloid beta uptake in Alzheimer's disease brain
36. Utility of ioflupane‐SPECT with multimodal imaging in dementia with Lewy bodies
37. NIA‐AA AD framework stage 2: Performance in the community
38. Genome‐wide association study of tau‐PET: Association of variant near NTNG2 with resistance to tau deposition
39. Preservation of white matter integrity on DTI 3 years after early menopausal hormone therapies
40. Multisite study of the relationships between antemortem [ 11 C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
41. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
42. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease
43. P4-282: MENTAL AND PHYSICAL ACTIVITY DURING THE 80-MINUTE UPTAKE TIME AFFECTS OFF-TARGET BINDING IN TAU PET SCANS (18F-FTP)
44. O1‐04‐05: PATHOLOGIC ASSOCIATIONS OF FDG PET IN LEWY BODY DISEASE
45. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
46. IC‐P‐116: COGNITIVE RESILIENCE IN 80+: PREDICTORS AND IMAGING CORRELATES OF COGNITION
47. IC‐P‐144: PRINCIPAL AXES OF PHENOTYPIC VARIABILITY IN ALZHEIMER'S DISEASE DERIVED FROM AN FDG‐PET BASED, UNSUPERVISED MACHINE LEARNING ALGORITHM
48. IC‐02‐05: THE INFLUENCE OF AGE ON REGIONAL [ 18 F]AV‐1451 PET, PITTSBURGH COMPOUND B PET AND MRI ATROPHY IN ATYPICAL ALZHEIMER'S DISEASE
49. P1‐414: STATINS AND BRAIN HEALTH: MEDICATION EFFECTS ON NEUROIMAGING BIOMARKERS IN OLDER INDIVIDUALS
50. P4‐319: CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER'S DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.